ArticleFrontiers in oncology2026
Case Report: Neurolymphomatosis of the sciatic nerve as a presentation of relapsed diffuse large B-cell lymphoma.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neurolymphomatosis (NL) is an uncommon manifestation of lymphoma caused by direct infiltration of the peripheral nervous system by lymphoma cells. Early recognition is particularly difficult when deep nerves such as the sciatic nerve are involved. Combining contrast-enhanced MRI and PET/CT to assess anatomic extent and metabolic activity, together with nerve ultrasound (US) to identify characteristic signs and guide biopsy, may improve diagnostic accuracy. Case presentation: A 71-year-old man with systemic diffuse large B-cell lymphoma (DLBCL), histologically confirmed by gastric biopsy, developed progressive left-leg neuropathic pain, numbness, and foot drop during rituximab maintenance after achieving complete remission (CR). Common peroneal nerve decompression yielded only transient pain relief. Nerve US subsequently showed marked thickening of the sciatic nerve and its branches, with a surrounding hypoechoic rim forming the characteristic "fried egg sign," together with increased perineural echogenicity. MRI showed abnormalities along the sciatic nerve course, and whole-body ^18F-FDG PET/CT demonstrated metabolically active disease along the sciatic nerve course and defined the overall extent of involvement. Ultrasound-guided core-needle biopsy (US-CNB) confirmed NL, and immunohistochemistry demonstrated CD20 positivity, supporting B-cell lymphoma involvement. Given the patient's age and risk of neurotoxicity, treatment with cyclophosphamide preconditioning followed by glofitamab plus obinutuzumab achieved rapid clinical improvement and partial remission (PR) on imaging. At 3 months, MRI showed interval reduction of the lesion, and follow-up US demonstrated resolution of the hypoechoic rim with decreased diameters of the sciatic, tibial, and common peroneal nerves. Conclusions: NL should be considered in patients with otherwise unexplained, progressive lower-limb neuropathy and a current or prior history of lymphoma. In this case, nerve US played a central role by demonstrating the characteristic "fried egg sign," localizing the lesion, and enabling US-CNB for tissue confirmation, while contrast-enhanced MRI and whole-body ^18F-FDG PET/CT provided complementary information on neural involvement and overall disease extent. An ultrasound-centered multimodal approach may help shorten time to diagnosis and facilitate timely treatment and neurological recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.